{"NCCN": [0, 52], "Clinical": [1], "Practice": [2], "Guidelines": [3, 53], "in": [4], "Oncology": [5], "(NCCN": [6], "Guidelines)": [7], "for": [8, 17, 26, 39, 54, 60], "Non-Small": [9], "Cell": [10], "Lung": [11], "Cancer": [12], "(NSCLC)": [13], "provide": [14], "recommended": [15], "management": [16], "patients": [18, 61], "with": [19, 32, 62], "NSCLC,": [20], "including": [21], "diagnosis,": [22], "primary": [23], "treatment,": [24], "surveillance": [25], "relapse,": [27], "and": [28, 65], "subsequent": [29], "treatment.": [30], "Patients": [31], "metastatic": [33, 63], "lung": [34], "cancer": [35], "who": [36], "are": [37, 44], "eligible": [38], "targeted": [40, 58], "therapies": [41, 59], "or": [42], "immunotherapies": [43], "now": [45], "surviving": [46], "longer.": [47], "This": [48], "selection": [49], "from": [50], "the": [51], "NSCLC": [55, 64], "focuses": [56], "on": [57], "actionable": [66], "mutations.": [67]}